Angel investor
Every published round Gokul Rajaram took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Gamgee | Seed | 23 Aug 2026 | $5.6m | Participant | trysignalbase.com, datapile.co | |
| Gamgee | Seed | 18 Aug 2026 | $4m | Participant | kucoin.com, thesaasnews.com, Dealroom, newshub.medianet.com.au, theunderbite.co |
Companies Gokul Rajaram has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Gamgee | startup building AI-designed personalized mRNA cancer vaccines for dogs | 18 Aug 2026, Seed | 2 | 0 |
Fund closes reported for Gokul Rajaram, as distinct from the investments it has made.
Companies Gokul Rajaram has backed that another company then bought. An exit for the holding, not a deal Gokul Rajaram did.
| Role | Organisation | Sources |
|---|---|---|
| No role recorded yet. Gokul Rajaram has been mentioned, but not yet attached to an organisation. Know their role? | ||
Stories naming Gokul Rajaram. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Veterinary biotech Gamgee has raised a four million dollar seed round led by Founders Fund, launching from Y Combinator to develop personalised mRNA cancer vaccines for dogs.
Also newshub.medianet.com.au·Dealroom·thesaasnews.com·kucoin.com